Thyroid Gland Disorder Treatment Market
Thyroid Gland Disorder Treatment Market by Disorder Type (Hyperthyroidism, Hypothyroidism and Thyroid Cancer), by Route of Administration (Oral, Parental and Others) - Global Industry Share, Growth, Competitive Analysis and Forecast, 2019-2025 Update Available - Forecast 2024-2030
Global Thyroid gland disorder treatment market is likely to grow at a significant pace over the forecast period. Factors augmenting the market growth are rising prevalence of thyroid disorders such as hyperthyroidism and hypothyroidism across the globe. According to the American Thyroid Association, in 2017, an estimated 20 million Americans have some form of thyroid disease. Moreover, more than 12% of the US population will develop thyroid disorder during their lifespan. This increasing prevalence of thyroid disorders is likely to augment the demand for treatment to cure thyroid gland disorders; thereby, fueling the market growth over the forecast period.
Thyroid gland disorder treatment market is segmented on the basis of disorder type, route of administration, and region. On the basis of disorder type, the market has been further segmented into hyperthyroidism, hypothyroidism, and thyroid cancer. Moreover, as per the route of administration, the market is diversified as oral, parental, and others. Additionally, the report analyzes the geographic area which covers this market includes North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to be the dominating market for thyroid gland disorder treatment market over the forecast period. However, Asia-Pacific region is expected to register the highest growth than any other regions across the globe.
Furthermore, the market consists of several market players that contribute significantly towards market growth. Key market players include Abbott Laboratories Inc., GlaxoSmithKline PLC, Mylan NV, Novartis AG, Sanofi SA, Bayer AG, AstraZeneca PLC, Pfizer, Inc., Allergan PLC, AbbVie, Inc., and so on. These market players adopt various strategies in order to stay competitive in the market. Strategies such as mergers and acquisitions, partnerships and collaborations, product launch, geographical expansion, and others are widely being adopted by the players.
Research Methodology
The market study of the global thyroid gland disorder treatment market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include
- Financial reports of companies involved in the market
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog
The report is intended for the service provider, research firms, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
Market Segmentation
Global Thyroid Gland Disorder Management Market Research and Analysis by Disorder Type
Global Thyroid Gland Disorder Treatment Market Research and Analysis by Route of Administration
The Report Covers
- Comprehensive research methodology of the global thyroid gland disorder treatment market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Insights about market determinants which are stimulating the global thyroid gland disorder treatment market.
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules &Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pfizer, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Abbott Laboratories, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. GlaxoSmithKline PLC
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Merck KGaA
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Novartis AG
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Thyroid Gland Disorder Treatment Market by Type
5.1.1. Hyperthyroidism
5.1.2. Hypothyroidism
5.1.3. Thyroid Cancer
5.2. Global Thyroid Gland Disorder Treatment Market by Route of Administration
5.2.1. Oral
5.2.2. Parenteral
5.2.3. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. AbbVie, Inc.
7.3. Acella Pharmaceutical LLC
7.4. Allergan PLC
7.5. Amgen, Inc.
7.6. Apitope International NV
7.7. Aspen Pharmacare Holdings Ltd.
7.8. AstraZeneca PLC
7.9. Bayer AG
7.10. Epivax, Inc.
7.11. F.Hoffman-La-Roche
7.12. Gemini Laboratories, LLC
7.13. GlaxoSmithKline PLC
7.14. IBSA Pharma Inc.
7.15. Macleods Pharmaceuticals Ltd.
7.16. Merck KGaA
7.17. Mylan NV
7.18. Novartis AG
7.19. Pfizer, Inc.
7.20. RLC Labs Inc.
7.21. Sanofi SA
7.22. Takeda Pharmaceutical Ltd.
1. GLOBAL THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. GLOBAL HYPERTHYROIDISM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL HYPOTHYROIDISM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL THYROID CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
6. GLOBAL ORAL MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL PARENTERAL MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
8. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
10. NORTH AMERICAN THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
11. NORTH AMERICAN THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
12. NORTH AMERICAN THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
13. EUROPEAN THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
14. EUROPEAN THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
15. EUROPEAN THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
16. ASIA-PACIFIC THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
17. ASIA-PACIFIC THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
18. ASIA-PACIFIC THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
19. REST OF THE WORLD THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
20. REST OF THE WORLD THYROID GLAND DISORDER TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
1. GLOBAL THYROID GLAND DISORDER TREATMENT MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. GLOBAL THYROID GLAND DISORDER TREATMENT MARKET SHARE BY ROUTE OF ADMINISTRATION, 2018 VS 2025 (%)
3. GLOBAL THYROID GLAND DISORDER TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
4. US THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
5. CANADA THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
6. UK THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
7. FRANCE THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
8. GERMANY THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
9. ITALY THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
10. SPAIN THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
11. REST OF EUROPE THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
12. INDIA THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
13. CHINA THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
14. JAPAN THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
15. REST OF ASIA-PACIFIC THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF THE WORLD THYROID GLAND DISORDER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
